Chemotherapy News and Research

Latest Chemotherapy News and Research

Bristol-Myers announces availability of ERBITUX for metastatic colorectal cancer treatment

Bristol-Myers announces availability of ERBITUX for metastatic colorectal cancer treatment

New drug combination releives neuropathic pain and improves sleep

New drug combination releives neuropathic pain and improves sleep

Orphan drug designation for pixantrone applied by Cell Therapeutics

Orphan drug designation for pixantrone applied by Cell Therapeutics

SATAI invests $1.045 million in Azaya Therapeutics

SATAI invests $1.045 million in Azaya Therapeutics

New research may enhance the treatment for blood cancer in children

New research may enhance the treatment for blood cancer in children

Younger women with metastatic colorectal cancer live longer than younger men

Younger women with metastatic colorectal cancer live longer than younger men

Response Genetics launches new genetic diagnostic test for gastric cancer

Response Genetics launches new genetic diagnostic test for gastric cancer

NIH awards Novelos and MGH $1M grant for the study of compounds for radiation-induced lung injury

NIH awards Novelos and MGH $1M grant for the study of compounds for radiation-induced lung injury

NovoCure initiates newly-diagnosed GBM clinical trial

NovoCure initiates newly-diagnosed GBM clinical trial

Pfizer to commence Phase 3 trial of oral c-Met and ALK inhibitor

Pfizer to commence Phase 3 trial of oral c-Met and ALK inhibitor

Morphotek announces preliminary data from Phase II trial of farletuzumab

Morphotek announces preliminary data from Phase II trial of farletuzumab

G-bor Bal-zsi's innovative research in drug resistance earns select honor

G-bor Bal-zsi's innovative research in drug resistance earns select honor

Folotyn approved for the treatment of Peripheral T-Cell Lymphoma

Folotyn approved for the treatment of Peripheral T-Cell Lymphoma

US Treasury Department clears YM BioSciences' nimotuzumab clinical program extension

US Treasury Department clears YM BioSciences' nimotuzumab clinical program extension

Baylor Health Care receives $20 million donation from Sammons Enterprises

Baylor Health Care receives $20 million donation from Sammons Enterprises

Research to improve the targeting of chemotherapeutic drugs to specific cells

Research to improve the targeting of chemotherapeutic drugs to specific cells

Huachansu may slow cancer progression

Huachansu may slow cancer progression

Research study supports reovirus and cisplatin combination for cancer treatment

Research study supports reovirus and cisplatin combination for cancer treatment

CTRC commences patient enrolment in Phase 2 clinical trial of REOLYSIN for metastatic melanoma

CTRC commences patient enrolment in Phase 2 clinical trial of REOLYSIN for metastatic melanoma

New method found for the treatment of pancreatic cancer

New method found for the treatment of pancreatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.